COMPREHENSIVE REVIEW OF CHRONIC LIMB-THREATENING ISCHEMIA: FROM PATHOPHYSIOLOGY TO INNOVATIVE TREATMENT APPROACHES
Open Access
- 26 December 2025
- journal article
- review article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(48))
Abstract
Introduction: Chronic Limb-Threatening Ischemia (CLTI) represents the most advanced stage of peripheral artery disease (PAD) and is associated with a high risk of major amputation and mortality. Characterized by rest pain, non-healing ulcers, or gangrene, CLTI reflects severe systemic atherosclerosis with widespread cardiovascular involvement. The disease burden is increasing globally, particularly in aging populations with diabetes or hypertension. Methods: A literature review of PubMed, Scopus, and Google Scholar summarized current evidence on the definition, pathophysiology, classification, diagnostic strategies, and management of CLTI. It also highlights emerging research directions, including novel endovascular and surgical revascularization techniques, biologic and cell-based therapies, and evolving approaches to patient-centered care. Results: Advances in imaging modalities and revascularization strategies particularly endovascular, surgical, and hybrid techniques have significantly improved limb salvage and survival rates. Recent studies emphasize the importance of individualized therapy and multidisciplinary management. Concurrently, innovative therapies focusing on angiogenesis, gene therapy, and regenerative medicine show promise for “no-option” patients, although further randomized trials are needed to validate long-term efficacy and safety. Conclusions: CLTI remains a complex and life-threatening condition requiring early diagnosis, comprehensive risk factor control, and personalized treatment planning. The integration of precision medicine, advanced imaging, and regenerative approaches holds the potential to redefine therapeutic strategies and improve patient outcomes. Future research should focus on optimizing patient selection, expanding access to limb-salvage interventions, and reducing global disease burden through preventive care.Keywords
This publication has 24 references indexed in Scilit:
- Clinical Outcomes in Patients with Chronic Limb-Threatening Ischemia with or Without Hyperpolypharmacy After RevascularizationAnnals of Vascular Surgery, 2025
- Association of Chronic Limb Ischemia Rutherford Classification with Clinical Outcomes Following Lower Extremity RevascularizationAnnals of Vascular Surgery, 2025
- Chronic Limb-Threatening IschemiaInterventional Cardiology Clinics, 2025
- Impact of Age Differences in Chronic Limb-Threatening Ischemia Outcomes in OctogenariansAnnals of Vascular Surgery, 2024
- The Value of Restaging WIfI (Wound, Ischemia, and Foot Infection) After Initial Vascular and Podiatric InterventionAnnals of Vascular Surgery, 2024
- Contemporary Medical Management of Peripheral Arterial DiseaseCardiovascular Drugs and Therapy, 2023
- Revascularisation of Chronic Limb Threatening Ischaemia in Patients with no Pedal Arteries Leads to Lower Midterm Limb SalvageEuropean Journal of Vascular and Endovascular Surgery, 2023
- Inflammation and Loss of Skeletal Muscle Mass in Chronic Limb Threatening IschemiaAnnals of Vascular Surgery, 2022
- Reinterventions in Patients with Claudication and Chronic Limb Threatening IschemiaAnnals of Vascular Surgery, 2022
- Global Vascular Guidelines on the Management of Chronic Limb-Threatening IschemiaEuropean Journal of Vascular and Endovascular Surgery, 2019